ANTX AN2 THERAPEUTICS INC

AN2 Therapeutics to Present at Oppenheimer Healthcare Life Sciences Conference

MENLO PARK, Calif.--(BUSINESS WIRE)--

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced that Eric Easom, Co-Founder, President and CEO will present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference.

Details of the event is as follows:

Oppenheimer 34th Annual Healthcare Life Sciences Conference (virtual)

  • Eric Easom, Co-Founder, President and CEO will provide a corporate overview on Wednesday, February 14, 2024 at 10:40am ET.

A webcast of the presentation can be accessed on the Investors section of the AN2 Therapeutics website at . An archived replay will be available for at least 30 days following the presentation.

About AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. Our initial candidate is epetraborole, which we are studying as a once-daily, oral treatment with a novel mechanism of action for patients with nontuberculous mycobacteria (NTM) lung disease, a rare, chronic, and progressive infectious disease caused by bacteria known as mycobacteria, that leads to irreversible lung damage and can be fatal. For more information, please visit our website at .

EN
30/01/2024

Underlying

ANTXAN2 THERAPEUTICS INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AN2 THERAPEUTICS INC

 PRESS RELEASE
Free
ANTX AN2 THERAPEUTIC...

AN2 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial R...

MENLO PARK, Calif.--(BUSINESS WIRE)-- AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today reported financial results for the fourth quarter and year ended December 31, 2023. “AN2’s cash position remains strong as we advance our innovative boron-based pipeline. Following the recent meeting of the independent Data Safety Monitoring Board, we continue to believe in the potential of epetraborole to become an important component of the backbone therapy for...

March 28, 2024 1 EN
 PRESS RELEASE
Free
ANTX AN2 THERAPEUTIC...

AN2 to Voluntarily Pause Enrollment in Phase 3 Part of Phase 2/3 Pivot...

MENLO PARK, Calif.--(BUSINESS WIRE)-- AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced the company’s decision to voluntarily pause Phase 3 enrollment in the seamless Phase 2/3 clinical trial (EBO-301) evaluating epetraborole in treatment-refractory MAC lung disease, pending further data review. The double-blind, placebo-controlled trial has two arms comparing epetraborole plus optimized background regimen (OBR) versus placebo plus OBR. The ...

February 12, 2024 1 EN
 PRESS RELEASE
Free
ANTX AN2 THERAPEUTIC...

AN2 Therapeutics to Present at Oppenheimer Healthcare Life Sciences Co...

MENLO PARK, Calif.--(BUSINESS WIRE)-- AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced that Eric Easom, Co-Founder, President and CEO will present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference. Details of the event is as follows: Oppenheimer 34th Annual Healthcare Life Sciences Conference (virtual) Eric Easom, Co-Founder, President and CEO will provide a corporate overview on Wednesday, February 14, 2024 at 10:40...

January 30, 2024 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 46.35
RCL ROYAL CARIBBEAN...
OC OWENS CORNING ... (+23)

Vermilion Compass: Weekly Equity Strategy

Lockout Rally Continues; Breakouts Piling Up Since our 11/21/23 Compass we have discussed on a weekly basis that even a minor 2-5% pullback is far from a guarantee, considering "breakaway gaps" and what appeared to be an ongoing "lockout rally," while also discussing that we would be buyers if a pullback did happen. All we got was a 1% peak to trough decline in the S&P 500, while the Nasdaq 100 (QQQ) pulled back 2.9% (though left the 11/14/23 gap unfilled). Now, the SPX and QQQ are breaking out...

RCL ROYAL CARIBBEAN GROUP
OC OWENS CORNING
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
GPS GAP INC.
BKE BUCKLE INC.
ANF ABERCROMBIE & FITCH CO. CLASS A
AEO AMERICAN EAGLE OUTFITTERS INC.
AWI ARMSTRONG WORLD INDUSTRIES INC.
MAS MASCO CORPORATION
BLD TOPBUILD CORP.
BLDR BUILDERS FIRSTSOURCE INC.
CCL CARNIVAL CORPORATION
POH3 CARNIVAL PLC
IBP INSTALLED BUILDING PRODUCTS INC.
SSD SIMPSON MANUFACTURING CO. INC.
PLSE PULSE BIOSCIENCES
GTHX G1 THERAPEUTICS
APLT APPLIED THERAPEUTICS
UFPI UFP INDUSTRIES INC.
AZEK THE AZEK COMPANY
ANTX AN2 THERAPEUTICS INC
PEPG PEPGEN INC
GYRE GYRE THERAPEUTICS INC
12/14/23 December 14, 2023 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 46.35
SYK STRYKER CORPORA...
RGLD ROYAL GOLD INC ... (+41)

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

SYK STRYKER CORPORATION
RGLD ROYAL GOLD INC
WING WINGSTOP INC.
EVEREST RE GROUP LTD.
R RYDER SYSTEM INC.
NEO NEOGENOMICS INC.
MPAA MOTORCAR PARTS OF AMERICA INC.
MELI MERCADOLIBRE INC.
M MACY'S INC
LWAY LIFEWAY FOODS INC.
INTC INTEL CORPORATION
HCI HCI GROUP INC.
CB CHUBB LIMITED
ARCO ARCOS DORADOS HOLDINGS INC. CLASS A
AMT AMERICAN TOWER CORPORATION
ALL ALLSTATE CORPORATION
UVE UNIVERSAL INSURANCE HOLDINGS INC.
ABC AMERISOURCEBERGEN CORPORATION
SGC SAGIANG IMPORT EXPORT CORP
108N RCL FOODS LTD
UEC UNIMIT ENGINEERING
CCL CARNIVAL CORPORATION
THG HANOVER INSURANCE GROUP INC.
AJG ARTHUR J. GALLAGHER & CO.
WRB W. R. BERKLEY CORPORATION
CRSP CRISPR THERAPEUTICS AG
HCC WARRIOR MET COAL INC.
DESP DESPEGAR.COM CORP.
FDBC FIDELITY D&D BANCORP INC.
SONO SONOS
ALXO ALX ONCOLOGY HOLDINGS
FOUR SHIFT4 PAYMENTS
GE GENERAL ELECTRIC CO.
RXST RXSIGHT INC
ACLX ARCELLX INC
ANTX AN2 THERAPEUTICS INC
DKNG DRAFTKINGS INC.
LUXH LUXURBAN HOTELS INC
ISRG ISRAIR GROUP LTD
UTIL HORIZONS CANADIAN UTILITY SERVICES HIGH DIVIDEND INDEX ETF
MMS LYXOR MSCI EMU SMALL CAP (DR) UCITS ETF
11/17/23 November 17, 2023 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch